T1	Participants 41 92	after bone marrow transplantation by pentoxifylline
T2	Participants 282 315	bone marrow transplantation (BMT)
T3	Participants 521 544	patients undergoing BMT
T4	Participants 611 688	140 patients undergoing either allogeneic (n = 51) or autologous BMT (n = 89)
T5	Participants 1921 1930	after BMT
